doi: 10.1111/imj.1967.16.3.205.
The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi
- PMID: 6056609
- DOI: 10.1111/imj.1967.16.3.205
Item in Clipboard
The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi
Australas Ann Med.
1967 Aug.
No abstract available
Similar articles
-
[When and how to prescribe uricosuric agents? The need for urinary alkalinization].Sem Hop Ther. 1974 Sep-Oct;50(7-8):449-52. Sem Hop Ther. 1974. PMID: 4445888 French. No abstract available.
-
A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.Clin Sci. 1968 Oct;35(2):353-62. Clin Sci. 1968. PMID: 5721238 No abstract available.
-
Allopurinol in patients with impaired renal function.Ann Rheum Dis. 1966 Nov;25(6 Suppl):681-7. doi: 10.1136/ard.25.Suppl_6.681. Ann Rheum Dis. 1966. PMID: 5958698 Free PMC article. No abstract available.
-
Treatment of gout.N Engl J Med. 1971 Dec 2;285(23):1303-6. doi: 10.1056/NEJM197112022852306. N Engl J Med. 1971. PMID: 4941493 Review. No abstract available.
-
Drug treatment of gout.Semin Drug Treat. 1971 Sep;1(2):119-47. Semin Drug Treat. 1971. PMID: 4949305 Review. No abstract available.
Cited by
-
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.Clin Pharmacokinet. 2007;46(8):623-44. doi: 10.2165/00003088-200746080-00001. Clin Pharmacokinet. 2007. PMID: 17655371 Review.